Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting ...Middle East

SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO...

Read More Details
Finally We wish PressBee provided you with enough information of ( Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting )

Also on site :

• Mossad thanks CIA for help with Operation Rising Lion
• Egypt vows no power cuts this summer, cites gas supply boost
• What to Know About the Investigation Into Influencer Gloria Zamora’s Death